Achieve Life Sciences
ACHV
29 hedge funds and large institutions have $2.12M invested in Achieve Life Sciences in 2016 Q4 according to their latest regulatory filings, with 5 funds opening new positions, 5 increasing their positions, 4 reducing their positions, and 5 closing their positions.
25% more repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 4
0.01% more ownership
Funds ownership: 0% → 0.01% (+0.01%)
0% more funds holding
Funds holding: 29 → 29 (0)
0% more first-time investments, than exits
New positions opened: 5 | Existing positions closed: 5
25% less capital invested
Capital invested by funds: $2.81M → $2.12M (-$690K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
+$56.3K |
| 2 |
VKH
Virtu KCG Holdings
New York
|
+$26.7K |
| 3 |
Citadel Advisors
Miami,
Florida
|
+$13.8K |
| 4 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$11.9K |
| 5 |
NCCM
Nine Chapters Capital Management
Short Hills,
New Jersey
|
+$7.9K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SCP
Steamboat Capital Partners
Rye,
New York
|
-$414K |
| 2 |
A
Abingworth
London,
United Kingdom
|
-$195K |
| 3 |
EGA
Eagle Global Advisors
Houston,
Texas
|
-$65K |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
-$44.5K |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$43K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
26
Group One Trading
Chicago,
Illinois
| $2K | – | – | – |
|
27
Morgan Stanley
New York
| $2K | – | – | – |
|
28
Bank of America
Charlotte,
North Carolina
| $1K | – | – | – |
|
|
CLOS
29
Compagnie Lombard Odier SCmA
1204 Geneva,
Switzerland
| $1K | – | – | – |
|
|
SCP
30
Steamboat Capital Partners
Rye,
New York
| – | -$414K | -372 | Closed |
|
|
A
31
Abingworth
London,
United Kingdom
| – | -$195K | -180 | Closed |
|
|
EGA
32
Eagle Global Advisors
Houston,
Texas
| – | -$65K | -58 | Closed |
|
|
33
UBS Group
Zurich,
Switzerland
| – | -$43K | -39 | Closed |
|
|
BFM
34
Boothbay Fund Management
New York
| – | -$31K | -28 | Closed |
|
ACHV Hedge Fund Activity: Q4 2016 in Review
29 of the 4,000 institutional investors tracked by Wall St. Rank reported a position in Achieve Life Sciences (ACHV) for Q4 2016, worth a combined $2.12M — down 25% from $2.81M a quarter earlier.
Fund positioning in ACHV was balanced in Q4 2016: 5 funds opened new positions, 5 closed out, 5 added to existing stakes and 4 trimmed.
The largest buyer was Renaissance Technologies, adding an estimated $56.3K. The largest seller was Steamboat Capital Partners, exiting entirely with an estimated $414K sold.
- 29 institutional investors held Achieve Life Sciences (ACHV) as of Q4 2016, unchanged from Q3 2016.
- Funds reported $2.12M of Achieve Life Sciences stock for Q4 2016, down 25% quarter-over-quarter.
- 5 funds opened new Achieve Life Sciences positions in Q4 2016 and 5 closed out, a net change of 0 holders.
- The largest Achieve Life Sciences buyer in Q4 2016 was Renaissance Technologies, an estimated $56.3K added.
- The largest Achieve Life Sciences seller in Q4 2016 was Steamboat Capital Partners, an estimated $414K sold.
Based on aggregated 13F filings for Q4 2016.